KarieraManagera
OFERTA PRACY

Associate Director, HEOR Strategy, Specialty

abbvie

Stany Zjednoczone · Mettawa
Hybrydowo
Umowa o pracęPełny etatOpublikowano 17 listopada 2026
Źródło: crawljobs.com
About AbbVie

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube.

The Associate Director, Health Economics & Outcomes Research (HEOR) Strategy, Specialty will serve as the strategic HEOR lead for assigned assets within the Hypothyroidism Therapeutic Area. The role will develop and advance integrated evidence strategies supporting launch readiness, value demonstration, market access, differentiation, and lifecycle management, partnering across the Integrated Brand Team and broader organization to inform asset and business decisions.

As an individual contributor, the Associate Director will provide strategic and scientific leadership while leveraging V&E Centers of Excellence (COEs) and research partners for technical execution. The successful candidate will demonstrate strong strategic judgment, cross-functional influence, and leadership potential to assume broader responsibilities over time.

Additional Information

This is a hybrid role based in Lake County, IL .

Responsibilities

Develop and evolve the integrated HEOR evidence strategy and roadmap , translating business, clinical, patient, and access evidence gaps into prioritized research initiatives aligned with asset strategy, launch milestones, and stakeholder needs.; Provide strategic and scientific direction across evidence-generation initiatives, including real-world evidence (RWE), patient and healthcare professional research, patient-reported outcomes, burden-of-illness and comparative-effectiveness research, and economic modeling.; Partner with V&E Centers of Excellence (COEs) and research partners to ensure methodological rigor, strategic alignment, prioritization, and timely evidence delivery while providing strategic direction and oversight .; Represent HEOR as a trusted strategic partner on cross-functional asset and launch teams, connecting insights across Commercial Marketing, Market Access, MHI/Value & Evidence, Clinical Development, Regulatory, and other relevant functions to inform integrated asset decisions.; Integrate and translate clinical, economic, humanistic, societal, and patient-centered evidence into a cohesive value narrative with clear implications for scientific, access, and business decision-making.; Anticipate changes in the payer, reimbursement, HTA, policy, and value-assessment environment and communicate implications, opportunities, risks, and recommendations to senior leaders and cross-functional decision-making forums.; Demonstrate leadership through influence, curiosity, and an enterprise mindset , using sound judgment and creativity to connect perspectives, build alignment, make timely decisions, and deliver in a fast-paced, ambiguous, and evolving environment .

Requirements

Advanced degree in health economics or a related discipline, with a minimum of 5 years of relevant experience for candidates with a Master’s degree or a minimum of 3 years of relevant experience for candidates with a PhD or other relevant doctoral degree (e.g., PharmD, MD).; Strong knowledge of HEOR methodologies , with experience in areas such as RWE and observational research, patient-reported outcomes, economic modeling, burden-of-illness, comparative effectiveness, patient and healthcare professional research, and/or evidence synthesis.; Demonstrated ability to translate asset, business, patient, and stakeholder needs into strategic evidence priorities and actionable research questions .; Experience supporting asset, brand, pipeline, and/or launch strategy , preferably for a pre-launch or launch-stage pharmaceutical asset.; Experience developing and translating evidence to support value demonstration, payer, market access, formulary, and reimbursement decision-making , with an understanding of the US payer and relevant HTA environment.; Proven ability to lead through influence , leverage technical experts and execution partners, and build alignment across complex cross-functional teams without formal authority.; Strong scientific judgment and executive communication skills , with the ability to synthesize complex information, connect the dots, and articulate a clear and cohesive story that engages senior leaders and cross-functional stakeholders.; Demonstrated enterprise mindset, curiosity, learning agility, and adaptability , with the ability to make sound decisions, deliver in ambiguous environments, and adapt to evolving business and organizational needs .; Experience in endocrinology, hypothyroidism, or another Specialty therapeutic area is a plus but not required.